Sacha Gnjatic to Aged
                                
                                
                                    This is a "connection" page, showing publications Sacha Gnjatic has written about Aged.
                                
                                
                                
                                    
                                        
                                                
    
        
        
        
            Connection Strength
            
                
            
            0.057
         
        
        
     
 
    
        
        - 
            An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020 10; 26(10):1636-1643.
            
            
                Score: 0.016
             
- 
            Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies. Gastroenterology. 2021 08; 161(2):715-718.e4.
            
            
                Score: 0.004
             
- 
            Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol. 2021 08; 34(8):1456-1467.
            
            
                Score: 0.004
             
- 
            Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms. Gastroenterology. 2021 06; 160(7):2435-2450.e34.
            
            
                Score: 0.004
             
- 
            A streamlined whole blood CyTOF workflow defines a circulating immune cell signature of COVID-19. Cytometry A. 2021 05; 99(5):446-461.
            
            
                Score: 0.004
             
- 
            A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward. J Hematol Oncol. 2020 07 14; 13(1):94.
            
            
                Score: 0.004
             
- 
            First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1. Clin Cancer Res. 2019 10 01; 25(19):5808-5817.
            
            
                Score: 0.004
             
- 
            First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1. Cancer Immunol Immunother. 2019 Jul; 68(7):1211-1222.
            
            
                Score: 0.004
             
- 
            Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat Med. 2018 12; 24(12):1845-1851.
            
            
                Score: 0.004
             
- 
            Phase 2 Trial of Gemcitabine, Cisplatin, plus Ipilimumab in Patients with Metastatic Urothelial Cancer and Impact of DNA Damage Response Gene Mutations on Outcomes. Eur Urol. 2018 05; 73(5):751-759.
            
            
                Score: 0.003
             
- 
            Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging. Sci Rep. 2017 05 26; 7(1):2452.
            
            
                Score: 0.003
             
- 
            NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer. Gynecol Oncol. 2017 06; 145(3):420-425.
            
            
                Score: 0.003